Breaking News Instant updates and real-time market news.

BIIB

Biogen

$269.10 /

+1.6 (+0.60%)

07:23
10/22/20
10/22
07:23
10/22/20
07:23

Biogen price target lowered to $350 from $359 at Credit Suisse

Credit Suisse analyst Evan Seigerman lowered the firm's price target on Biogen to $350 from $359 and keeps an Outperform rating on the shares. Despite a decent quarter with top and bottom-line beats, the erosion of Tecfidera is abundantly clear and could pressure margins over the balance of 2020 and into 2021, the analyst contends. To this end guidance was cut $850M top-line and $2.00 bottom-line, deviating from the typical 2-times per year guidance cycle for Biogen, he adds. Still, Seigerman does not think the near-term financials matter much for Biogen shares, as the sole point of investor focus is the very near-term AdCom meeting.

  • 06

    Nov

  • 07

    Mar

BIIB Biogen
$269.10 /

+1.6 (+0.60%)

10/22/20 Barclays
Biogen price target lowered to $265 from $275 at Barclays
10/21/20 Piper Sandler
Piper Sandler 'firmly' on the sidelines after Biogen's Q3 report
10/21/20 Evercore ISI
Biogen release includes several important pipeline updates, says Evercore ISI
10/19/20 RBC Capital
Biogen price target lowered to $268 from $281 at RBC Capital

TODAY'S FREE FLY STORIES

Downgrade
PPL Corp. downgraded to Neutral on Brexit and GBP uncertainty at BofA » 06:46
11/30/20
11/30
06:46
11/30/20
06:46
PPL

PPL Corp.

$29.23 /

-0.17 (-0.58%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPL PPL Corp.
$29.23 /

-0.17 (-0.58%)

PPL PPL Corp.
$29.23 /

-0.17 (-0.58%)

05:33 Today BofA
PPL Corp. downgraded to Neutral from Buy at BofA
08/19/20
Fly Intel: Top five analyst downgrades
08/19/20 Mizuho
PPL Corp. downgraded to Neutral from Buy at Mizuho
08/19/20 Mizuho
PPL Corp. downgraded to Neutral from Buy at Mizuho
PPL PPL Corp.
$29.23 /

-0.17 (-0.58%)

Earnings
36Kr Holdings reports Q3 EPS (RMB0.014) vs. (RMB2.535) last year » 06:46
11/30/20
11/30
06:46
11/30/20
06:46
KRKR

36Kr Holdings

$3.45 /

+0.025 (+0.73%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRKR 36Kr Holdings
$3.45 /

+0.025 (+0.73%)

KRKR 36Kr Holdings
$3.45 /

+0.025 (+0.73%)

12/04/19 Needham
36Kr Holdings initiated with a Buy at Needham
KRKR 36Kr Holdings
$3.45 /

+0.025 (+0.73%)

KRKR 36Kr Holdings
$3.45 /

+0.025 (+0.73%)

Downgrade
PTC Therapeutics downgraded to Underperform from Sector Perform at RBC Capital » 06:45
11/30/20
11/30
06:45
11/30/20
06:45
PTCT

PTC Therapeutics

$63.97 /

+0.46 (+0.72%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTCT PTC Therapeutics
$63.97 /

+0.46 (+0.72%)

PTCT PTC Therapeutics
$63.97 /

+0.46 (+0.72%)

05:22 Today RBC Capital
PTC Therapeutics downgraded to Underperform from Sector Perform at RBC Capital
10/30/20 Citi
Citi downgrades PTC Therapeutics to Neutral, sees shares being range-bound
10/30/20 Citi
PTC Therapeutics downgraded to Neutral from Buy at Citi
10/30/20 Cantor Fitzgerald
PTC Therapeutics price target lowered to $67 from $75 at Cantor Fitzgerald
PTCT PTC Therapeutics
$63.97 /

+0.46 (+0.72%)

PTCT PTC Therapeutics
$63.97 /

+0.46 (+0.72%)

Recommendations
New Oriental Education weakness a buying opportunity, says CLSA » 06:45
11/30/20
11/30
06:45
11/30/20
06:45
EDU

New Oriental Education

$168.55 /

-0.25 (-0.15%)

CLSA analyst Youngrin Kim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDU New Oriental Education
$168.55 /

-0.25 (-0.15%)

EDU New Oriental Education
$168.55 /

-0.25 (-0.15%)

11/25/20 Morgan Stanley
OneSmart downgraded to Equal Weight on margin pressure at Morgan Stanley
10/26/20 JPMorgan
TAL Education downgraded to Neutral from Overweight at JPMorgan (Friday)
10/15/20 Citi
New Oriental Education price target raised to $198 from $160 at Citi
10/14/20 Benchmark
New Oriental Education price target raised to $195 from $148 at Benchmark
EDU New Oriental Education
$168.55 /

-0.25 (-0.15%)

EDU New Oriental Education
$168.55 /

-0.25 (-0.15%)

Downgrade
PNC Financial downgraded to Equal Weight from Overweight at Stephens » 06:43
11/30/20
11/30
06:43
11/30/20
06:43
PNC

PNC Financial

$139.79 /

-0.88 (-0.63%)

, BLK

BlackRock

$718.40 /

+14.63 (+2.08%)

, BBVA

BBVA

$4.65 /

+0.195 (+4.38%)

Stephens analyst Terry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PNC PNC Financial
$139.79 /

-0.88 (-0.63%)

BLK BlackRock
$718.40 /

+14.63 (+2.08%)

BBVA BBVA
$4.65 /

+0.195 (+4.38%)

PNC PNC Financial
$139.79 /

-0.88 (-0.63%)

11/23/20
Fly Intel: Top five analyst upgrades
11/23/20 UBS
PNC Financial upgraded to Neutral from Sell at UBS
11/18/20 Keefe Bruyette
PNC Financial price target raised to $130 from $124 at Keefe Bruyette
11/17/20 Baird
PNC Financial acquisition a good use of capital, says Baird
BLK BlackRock
$718.40 /

+14.63 (+2.08%)

11/23/20 UBS
PNC Financial upgraded to Neutral from Sell at UBS
11/11/20 Deutsche Bank
BlackRock price target raised to $795 from $685 at Deutsche Bank
10/15/20 BMO Capital
BlackRock price target raised to $602 from $594 at BMO Capital
10/14/20 Deutsche Bank
BlackRock price target raised to $685 from $661 at Deutsche Bank
BBVA BBVA
$4.65 /

+0.195 (+4.38%)

11/27/20 BofA
BBVA upgraded to Neutral at BofA after Banco Sabadell merger called off
11/27/20 BofA
BBVA upgraded to Neutral from Underperform at BofA
11/24/20 Morgan Stanley
BBVA price target raised to EUR 4 from EUR 2.90 at Morgan Stanley
11/23/20 UBS
PNC Financial upgraded to Neutral from Sell at UBS
PNC PNC Financial
$139.79 /

-0.88 (-0.63%)

BLK BlackRock
$718.40 /

+14.63 (+2.08%)

BBVA BBVA
$4.65 /

+0.195 (+4.38%)

  • 13
    May
PNC PNC Financial
$139.79 /

-0.88 (-0.63%)

BLK BlackRock
$718.40 /

+14.63 (+2.08%)

BBVA BBVA
$4.65 /

+0.195 (+4.38%)

PNC PNC Financial
$139.79 /

-0.88 (-0.63%)

BLK BlackRock
$718.40 /

+14.63 (+2.08%)

BBVA BBVA
$4.65 /

+0.195 (+4.38%)

PNC PNC Financial
$139.79 /

-0.88 (-0.63%)

BLK BlackRock
$718.40 /

+14.63 (+2.08%)

Hot Stocks
K92 Mining announces results from diamond drilling of Kora deposit » 06:43
11/30/20
11/30
06:43
11/30/20
06:43
KNTNF

K92 Mining

$0.00 /

+ (+0.00%)

K92 Mining announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KNTNF K92 Mining
$0.00 /

+ (+0.00%)

10/13/20 Scotiabank
K92 Mining price target raised to C$8.50 from C$7.75 at Scotiabank
08/28/20 Canaccord
Canaccord backs Buy on K92 Mining after Kora deposit drill results
08/28/20 PI Financial
K92 Mining price target raised to C$10 from C$8.25 at PI Financial
07/29/20 BMO Capital
K92 Mining price target raised to C$8 from C$6 at BMO Capital
Upgrade
Montrose Environmental upgraded to Buy from Neutral at BofA » 06:41
11/30/20
11/30
06:41
11/30/20
06:41
MEG

Montrose Environmental

$28.40 /

-1.165 (-3.94%)

BofA analyst Andrew Obin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEG Montrose Environmental
$28.40 /

-1.165 (-3.94%)

MEG Montrose Environmental
$28.40 /

-1.165 (-3.94%)

06:05 Today BofA
Montrose Environmental upgraded to Buy from Neutral at BofA
08/17/20
Fly Intel: Top five analyst initiations
08/17/20 Capital One
Montrose Environmental initiated with an Overweight at Capital One
08/17/20 William Blair
Montrose Environmental initiated with an Outperform at William Blair
MEG Montrose Environmental
$28.40 /

-1.165 (-3.94%)

  • 25
    Nov
  • 23
    Jul
MEG Montrose Environmental
$28.40 /

-1.165 (-3.94%)

MEG Montrose Environmental
$28.40 /

-1.165 (-3.94%)

Hot Stocks
Contango Oil & Gas announces private equity capital raise » 06:40
11/30/20
11/30
06:40
11/30/20
06:40
MCF

Contango Oil & Gas

$1.65 /

-0.045 (-2.65%)

Contango Oil & Gas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCF Contango Oil & Gas
$1.65 /

-0.045 (-2.65%)

MCF Contango Oil & Gas
$1.65 /

-0.045 (-2.65%)

Recommendations
Micron to benefit from persistent mobile DRAM shortages, says Mizuho » 06:40
11/30/20
11/30
06:40
11/30/20
06:40
MU

Micron

$64.23 /

+0.81 (+1.28%)

Mizuho analyst Vijay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MU Micron
$64.23 /

+0.81 (+1.28%)

MU Micron
$64.23 /

+0.81 (+1.28%)

11/23/20 Deutsche Bank
Micron price target raised to $70 from $60 at Deutsche Bank
11/23/20 Mizuho
Micron price target raised to $70 from $56 at Mizuho
10/29/20 Craig-Hallum
FormFactor price target raised to $35 from $30 at Craig-Hallum
10/19/20 Lynx
Intel/SK Hynix deal impact to Western, Micron 'manageable,' says Lynx
MU Micron
$64.23 /

+0.81 (+1.28%)

MU Micron
$64.23 /

+0.81 (+1.28%)

MU Micron
$64.23 /

+0.81 (+1.28%)

MU Micron
$64.23 /

+0.81 (+1.28%)

Hot Stocks
Contango Oil & Gas to acquire assets in Big Horn, Permian, Powder River Basins » 06:40
11/30/20
11/30
06:40
11/30/20
06:40
MCF

Contango Oil & Gas

$1.65 /

-0.045 (-2.65%)

Contango Oil & Gas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCF Contango Oil & Gas
$1.65 /

-0.045 (-2.65%)

MCF Contango Oil & Gas
$1.65 /

-0.045 (-2.65%)

Hot Stocks
Novavax completes enrollment in UK Phase 3 trial, South Africa Phase 2b trial » 06:37
11/30/20
11/30
06:37
11/30/20
06:37
NVAX

Novavax

$124.01 /

+21.49 (+20.96%)

Novavax provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVAX Novavax
$124.01 /

+21.49 (+20.96%)

NVAX Novavax
$124.01 /

+21.49 (+20.96%)

11/17/20 H.C. Wainwright
Novavax price target lowered to $207 from $290 at H.C. Wainwright
10/30/20 Cantor Fitzgerald
Cantor says Novavax vaccine could be 'best-in-class,' but not 'first-in-class'
10/22/20 B. Riley Securities
Novavax price target lowered to $223 from $257 at B. Riley Securities
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
NVAX Novavax
$124.01 /

+21.49 (+20.96%)

NVAX Novavax
$124.01 /

+21.49 (+20.96%)

NVAX Novavax
$124.01 /

+21.49 (+20.96%)

NVAX Novavax
$124.01 /

+21.49 (+20.96%)

Hot Stocks
Quarterhill subsidiary licenses wireless LTE patent portfolio » 06:37
11/30/20
11/30
06:37
11/30/20
06:37
QTRHF

Quarterhill

$1.21 /

+ (+0.00%)

Wi-LAN, a Quarterhill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QTRHF Quarterhill
$1.21 /

+ (+0.00%)

QTRHF Quarterhill
$1.21 /

+ (+0.00%)

08/10/20 CIBC
Quarterhill price target raised to C$4 from C$3.47 at CIBC
Upgrade
U.S. Bancorp upgraded to Overweight from Equal Weight at Stephens » 06:37
11/30/20
11/30
06:37
11/30/20
06:37
USB

U.S. Bancorp

$44.17 /

-0.53 (-1.19%)

Stephens analyst Terry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

05:17 Today Morgan Stanley
U.S. Bancorp upgraded to Equal Weight from Underweight at Morgan Stanley
10/07/20 BofA
U.S. Bancorp upgraded to Neutral from Underperform at BofA
10/07/20 BofA
U.S. Bancorp upgraded to Neutral from Underperform at BofA
10/06/20 JPMorgan
U.S. Bancorp price target raised to $43.50 from $37.50 at JPMorgan
USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

Recommendations
Bristol-Myers price target raised to $77 from $73 at Citi » 06:36
11/30/20
11/30
06:36
11/30/20
06:36
BMY

Bristol-Myers

$63.20 /

+0.3 (+0.48%)

Citi analyst Andrew Baum…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$63.20 /

+0.3 (+0.48%)

BMY Bristol-Myers
$63.20 /

+0.3 (+0.48%)

11/23/20 BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/17/20 Mizuho
Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho
11/16/20 Societe Generale
Bristol-Myers upgraded to Buy from Hold at Societe Generale
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein
BMY Bristol-Myers
$63.20 /

+0.3 (+0.48%)

BMY Bristol-Myers
$63.20 /

+0.3 (+0.48%)

BMY Bristol-Myers
$63.20 /

+0.3 (+0.48%)

BMY Bristol-Myers
$63.20 /

+0.3 (+0.48%)

Upgrade
Welltower upgraded to Neutral from Underperform at BofA » 06:35
11/30/20
11/30
06:35
11/30/20
06:35
WELL

Welltower

$65.24 /

-0.03 (-0.05%)

BofA analyst Joshua…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WELL Welltower
$65.24 /

-0.03 (-0.05%)

WELL Welltower
$65.24 /

-0.03 (-0.05%)

06:04 Today BofA
Welltower upgraded to Neutral from Underperform at BofA
11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Wells Fargo
Welltower downgraded to Equal Weight from Overweight at Wells Fargo
11/16/20 Wells Fargo
Welltower downgraded to Equal Weight from Overweight at Wells Fargo
WELL Welltower
$65.24 /

-0.03 (-0.05%)

WELL Welltower
$65.24 /

-0.03 (-0.05%)

Upgrade
Ventas double-upgraded to Buy from Underperform at BofA » 06:35
11/30/20
11/30
06:35
11/30/20
06:35
VTR

Ventas

$49.00 /

-0.23 (-0.47%)

BofA analyst Joshua…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VTR Ventas
$49.00 /

-0.23 (-0.47%)

VTR Ventas
$49.00 /

-0.23 (-0.47%)

06:04 Today BofA
Ventas upgraded to Buy from Underperform at BofA
11/12/20 KeyBanc
Ventas price target raised to $35 from $23 at KeyBanc
11/11/20 RBC Capital
Ventas price target raised to $54 from $45 at RBC Capital
11/10/20 Jefferies
Jefferies upgrades Ventas to Hold on post-pandemic view
VTR Ventas
$49.00 /

-0.23 (-0.47%)

VTR Ventas
$49.00 /

-0.23 (-0.47%)

VTR Ventas
$49.00 /

-0.23 (-0.47%)

Hot Stocks
China Customer Relations Centers receives $5.37 per share going private offer » 06:34
11/30/20
11/30
06:34
11/30/20
06:34
CCRC

China Customer Relations Centers

$4.73 /

+0.08 (+1.72%)

China Customer Relations…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Intercept risk/reward favorable after pullback, says Citi » 06:34
11/30/20
11/30
06:34
11/30/20
06:34
ICPT

Intercept

$37.29 /

-0.01 (-0.03%)

Citi analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ICPT Intercept
$37.29 /

-0.01 (-0.03%)

ICPT Intercept
$37.29 /

-0.01 (-0.03%)

06:31 Today Citi
CymaBay price target raised to $10 from $9 at Citi
11/20/20 B. Riley Securities
Intercept price target lowered to $74 from $97 at B. Riley Securities
11/16/20 RBC Capital
RBC says new AE data on Ocaliva's Intercept 'does not reassure'
11/16/20 Piper Sandler
Piper says 'underwhelming' data from Novo Nordisk a 'big win' for Intercept
ICPT Intercept
$37.29 /

-0.01 (-0.03%)

  • 18
    Aug
ICPT Intercept
$37.29 /

-0.01 (-0.03%)

ICPT Intercept
$37.29 /

-0.01 (-0.03%)

Hot Stocks
Northern Genesis Acquisition, Lion Electric announce business combination » 06:34
11/30/20
11/30
06:34
11/30/20
06:34
NGA

Northern Genesis Acquisition

$13.04 /

+0.395 (+3.12%)

The Lion Electric Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 18
    Aug
NGA Northern Genesis Acquisition
$13.04 /

+0.395 (+3.12%)

Upgrade
Omega Healthcare double-upgraded to Buy from Underperform at BofA » 06:33
11/30/20
11/30
06:33
11/30/20
06:33
OHI

Omega Healthcare

$35.86 /

-0.41 (-1.13%)

BofA analyst Joshua…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OHI Omega Healthcare
$35.86 /

-0.41 (-1.13%)

OHI Omega Healthcare
$35.86 /

-0.41 (-1.13%)

06:04 Today BofA
Omega Healthcare upgraded to Buy from Underperform at BofA
10/02/20 Mizuho
Omega Healthcare price target raised to $34 from $30 at Mizuho
10/02/20 Mizuho
Omega Healthcare price target raised to $34 from $30 at Mizuho
09/14/20 Truist
Omega Healthcare price target raised to $34 from $32 at Truist
OHI Omega Healthcare
$35.86 /

-0.41 (-1.13%)

Recommendations
CymaBay price target raised to $10 from $9 at Citi » 06:31
11/30/20
11/30
06:31
11/30/20
06:31
CBAY

CymaBay

$7.42 /

+0.19 (+2.63%)

, ICPT

Intercept

$37.29 /

-0.01 (-0.03%)

Citi analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBAY CymaBay
$7.42 /

+0.19 (+2.63%)

ICPT Intercept
$37.29 /

-0.01 (-0.03%)

CBAY CymaBay
$7.42 /

+0.19 (+2.63%)

11/06/20 Raymond James
CymaBay price target raised to $12 at Raymond James after Q3 report
09/25/20 Piper Sandler
CymaBay beating Genfit in primary biliary cholangitis race, says Piper Sandler
09/09/20 B. Riley FBR
CymaBay price target raised to $13 from $9 at B. Riley FBR
08/27/20 Piper Sandler
Piper Sandler 'astonished' by seladelpar's long-term benefits
ICPT Intercept
$37.29 /

-0.01 (-0.03%)

11/20/20 B. Riley Securities
Intercept price target lowered to $74 from $97 at B. Riley Securities
11/16/20 RBC Capital
RBC says new AE data on Ocaliva's Intercept 'does not reassure'
11/16/20 Piper Sandler
Piper says 'underwhelming' data from Novo Nordisk a 'big win' for Intercept
11/10/20 Raymond James
Intercept upgraded to Outperform from Market Perform at Raymond James
CBAY CymaBay
$7.42 /

+0.19 (+2.63%)

ICPT Intercept
$37.29 /

-0.01 (-0.03%)

  • 18
    Aug
ICPT Intercept
$37.29 /

-0.01 (-0.03%)

CBAY CymaBay
$7.42 /

+0.19 (+2.63%)

ICPT Intercept
$37.29 /

-0.01 (-0.03%)

CBAY CymaBay
$7.42 /

+0.19 (+2.63%)

Hot Stocks
Blue Apron appoints Charlean Gmunder as COO » 06:31
11/30/20
11/30
06:31
11/30/20
06:31
APRN

Blue Apron

$7.60 /

+0.74 (+10.79%)

, UAL

United Airlines

$45.49 /

-0.15 (-0.33%)

Blue Apron Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APRN Blue Apron
$7.60 /

+0.74 (+10.79%)

UAL United Airlines
$45.49 /

-0.15 (-0.33%)

APRN Blue Apron
$7.60 /

+0.74 (+10.79%)

10/30/20 Canaccord
Blue Apron price target lowered to $14 from $18 at Canaccord
07/30/20 Canaccord
Canaccord upgrades Blue Apron as growth returns
07/30/20 Canaccord
Blue Apron upgraded to Buy from Hold at Canaccord
02/20/20 SunTrust
Blue Apron price target lowered to $5 from $8 at SunTrust
UAL United Airlines
$45.49 /

-0.15 (-0.33%)

11/18/20 William Blair
Boeing 737 Max approval 'a modest positive' for ViaSat, says William Blair
11/17/20 Jefferies
United Airlines initiated with a Hold at Jefferies
11/12/20 Exane BNP Paribas
United Airlines initiated with an Underperform at Exane BNP Paribas
10/12/20
Fly Intel: Top five analyst downgrades
APRN Blue Apron
$7.60 /

+0.74 (+10.79%)

UAL United Airlines
$45.49 /

-0.15 (-0.33%)

  • 06
    Aug
  • 22
    Apr
UAL United Airlines
$45.49 /

-0.15 (-0.33%)

APRN Blue Apron
$7.60 /

+0.74 (+10.79%)

UAL United Airlines
$45.49 /

-0.15 (-0.33%)

APRN Blue Apron
$7.60 /

+0.74 (+10.79%)

UAL United Airlines
$45.49 /

-0.15 (-0.33%)

Recommendations
Applied DNA Sciences price target lowered to $20 from $22 at H.C. Wainwright » 06:29
11/30/20
11/30
06:29
11/30/20
06:29
APDN

Applied DNA Sciences

$7.17 /

+0.39 (+5.75%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APDN Applied DNA Sciences
$7.17 /

+0.39 (+5.75%)

APDN Applied DNA Sciences
$7.17 /

+0.39 (+5.75%)

07/20/20 H.C. Wainwright
Applied DNA Sciences price target raised to $22 from $18 at H.C. Wainwright
07/02/20
Fly Intel: Top five analyst initiations
07/02/20 H.C. Wainwright
Applied DNA Sciences initiated with a Buy at H.C. Wainwright
05/05/20 Maxim
Applied DNA Sciences price target raised to $18 from $8 at Maxim
APDN Applied DNA Sciences
$7.17 /

+0.39 (+5.75%)

Downgrade
Rhythm Pharmaceuticals downgraded to Neutral from Buy at BofA » 06:28
11/30/20
11/30
06:28
11/30/20
06:28
RYTM

Rhythm Pharmaceuticals

$29.27 /

+5.16 (+21.40%)

BofA analyst Tazeen Ahmad…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RYTM Rhythm Pharmaceuticals
$29.27 /

+5.16 (+21.40%)

RYTM Rhythm Pharmaceuticals
$29.27 /

+5.16 (+21.40%)

11/27/20 Stifel
Rhythm's Imcivree label 'reads bullish' for possible basket trial, says Stifel
10/26/20 Stifel
Rhythm Pharmaceuticals price target raised to $36 from $31 at Stifel
01/08/20 Goldman Sachs
Rhythm Pharmaceuticals initiated with a Sell at Goldman Sachs
RYTM Rhythm Pharmaceuticals
$29.27 /

+5.16 (+21.40%)

RYTM Rhythm Pharmaceuticals
$29.27 /

+5.16 (+21.40%)

Recommendations
Parker-Hannifin price target raised to $303 from $256 at Barclays » 06:28
11/30/20
11/30
06:28
11/30/20
06:28
PH

Parker-Hannifin

$272.80 /

-1.71 (-0.62%)

Barclays analyst Julian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PH Parker-Hannifin
$272.80 /

-1.71 (-0.62%)

PH Parker-Hannifin
$272.80 /

-1.71 (-0.62%)

11/10/20 Argus
Parker-Hannifin price target raised to $280 from $210 at Argus
11/10/20 BMO Capital
Parker-Hannifin price target raised to $275 from $225 at BMO Capital
11/06/20 Deutsche Bank
Parker-Hannifin price target raised to $277 from $240 at Deutsche Bank
10/13/20 Deutsche Bank
Parker-Hannifin price target raised to $240 from $225 at Deutsche Bank
PH Parker-Hannifin
$272.80 /

-1.71 (-0.62%)

PH Parker-Hannifin
$272.80 /

-1.71 (-0.62%)

PH Parker-Hannifin
$272.80 /

-1.71 (-0.62%)

PH Parker-Hannifin
$272.80 /

-1.71 (-0.62%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.